BackKorsana Biosciences Overview

Korsana Biosciences Total Liabilities

Korsana Biosciences's total liabilities is $46M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$45.56M
↑ 5094.64% YoYΔ $44.68M vs prior year quarter

Peer trimmed avg / median

Loading

Korsana Biosciences Total Liabilities History

Loading

Korsana Biosciences vs. peers: Total Liabilities Comparison

Loading

Korsana Biosciences Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Korsana Biosciences (KRSA) FAQ

The latest total liabilities for KRSA is $46M as of September 2026. That compares with $880K in the prior-year period — up 5094.6% year over year. Investors often review this figure alongside Korsana Biosciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, KRSA's total liabilities moved from $880K to $46M — a 5094.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Korsana Biosciences's operating scale or balance-sheet position.

A total liabilities figure of $46M for KRSA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting KRSA's total liabilities ($46M), review year-over-year change from $880K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Korsana Biosciences's total liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.